Hashimoto H, Chatterjee S, Berger N A
Department of Medicine, Case Western Reserve University, School of Medicine, Cleveland, Ohio 44106-4937, USA.
Cancer Res. 1995 Sep 15;55(18):4029-35.
Bcl-2 has been shown to inhibit apoptosis induced by several anticancer agents and to cause a dissociation between etoposide (VP-16)-induced protein-cross-linked DNA strand breaks and VP-16-induced cell death. We suggested previously that VP-16-induced cytotoxicity is mediated by a series of events leading from cleavable complex formation to aberrant DNA recombination, as measured by sister chromatid exchange (SCE) and Southern blot analysis of the hypoxanthine phosphoribosyl transferase (hprt) gene mutations. To further evaluate this hypothesis and to determine whether Bcl-2 could affect any steps leading to the aberrant DNA recombination process, we stably transfected an expression vector containing human Bcl-2 cDNA into V79 Chinese hamster cells. This transfection resulted in overexpression of the Bcl-2 gene product. We subsequently quantitated the relationship between VP-16-induced cytotoxicity, DNA strand breaks, SCE, and mutant frequency at the hprt locus in these Bcl-2-overexpressing cells. Two independent Bcl-2-overexpressing cell lines, BCL2/2 and BCL2/4, showed 3-5 times higher survival at 15 microM VP-16 compared with parental V79 cells or control NeoR cells that were obtained by transfecting V79 cells with the expression vector containing the G-418 resistance gene only. DNA single-strand breaks induced by VP-16 were similar in parental V79, control NeoR, BCL2/2, and BCL2/4 cells. In contrast, VP-16 induced significantly less SCE in Bcl-2-overexpressing cell lines compared with parental V79 and control NeoR cells. The SCE/chromosome induced by 15 microM VP-16 were 0.65, 0.42, 0.09, and 0.10, respectively, in V79, NeoR, BCL2/2, and BCL2/4. In addition, there was an excellent correlation between VP-16-induced SCE and cytotoxicity in all cell lines. Furthermore, VP-16-induced mutant frequencies at the hprt locus were 5-10 times less in BCL-2/2 and BCL-2/4 cells than those observed in the V79 or NeoR control cells. These results indicate that overexpression of Bcl-2 is associated with reduction in VP-16-induced genetic recombination, mutation, and cytotoxicity. Moreover, they suggest that Bcl-2 modulates cytotoxicity of VP-16 between cleavable complex formation and subsequent induction of DNA recombination events. Thus, our results provide important support for the hypothesis that VP-16-induced cytotoxicity is associated with aberrant recombination events, including gene deletions and rearrangements.
已证实Bcl-2可抑制多种抗癌药物诱导的细胞凋亡,并导致依托泊苷(VP-16)诱导的蛋白质交联DNA链断裂与VP-16诱导的细胞死亡之间出现解离。我们之前曾提出,VP-16诱导的细胞毒性是由一系列事件介导的,这些事件从可切割复合物的形成到异常的DNA重组,可通过姐妹染色单体交换(SCE)以及次黄嘌呤磷酸核糖转移酶(hprt)基因突变的Southern印迹分析来衡量。为了进一步评估这一假说,并确定Bcl-2是否会影响导致异常DNA重组过程的任何步骤,我们将包含人Bcl-2 cDNA的表达载体稳定转染至V79中国仓鼠细胞中。这种转染导致了Bcl-2基因产物的过表达。随后,我们对这些Bcl-2过表达细胞中VP-16诱导的细胞毒性、DNA链断裂、SCE以及hprt基因座处的突变频率之间的关系进行了定量分析。与亲代V79细胞或仅用含有G-418抗性基因的表达载体转染V79细胞而获得的对照NeoR细胞相比,两个独立的Bcl-2过表达细胞系BCL2/2和BCL2/4在15 microM VP-16处理下的存活率高出3至5倍。VP-16诱导的DNA单链断裂在亲代V79细胞、对照NeoR细胞、BCL2/2细胞和BCL2/4细胞中相似。相比之下,与亲代V79细胞和对照NeoR细胞相比,VP-16在Bcl-2过表达细胞系中诱导的SCE显著减少。15 microM VP-16诱导的V79、NeoR、BCL2/2和BCL2/4细胞中SCE/染色体数分别为0.65、0.42、0.09和0.10。此外,在所有细胞系中,VP-16诱导的SCE与细胞毒性之间存在良好的相关性。此外,VP-16在hprt基因座处诱导的突变频率在BCL-2/2和BCL-2/4细胞中比在V79或NeoR对照细胞中观察到的低5至10倍。这些结果表明,Bcl-2的过表达与VP-16诱导的基因重组、突变和细胞毒性的降低有关。此外,这些结果表明Bcl-2在可切割复合物形成与随后的DNA重组事件诱导之间调节VP-16的细胞毒性。因此,我们的结果为VP-16诱导的细胞毒性与包括基因缺失和重排在内的异常重组事件相关这一假说提供了重要支持。